We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Directed Verdict Issued In Cymbalta Withdrawal Trial During 3rd Day Of Testimony

(August 14, 2015, 10:45 AM EDT) -- LOS ANGELES — A California federal judge presiding over a Cymbalta withdrawal trial on Aug. 13 issued a directed verdict during the third day of trial (Erin Hexum, et al. v. Eli Lilly and Company, No. 13-2701, C.D. Calif.).

A source told Mealey Publications that U.S. Judge Steven V. Wilson of the Central District of California issued a ruling that “meaningfully limited” the testimony of a plaintiff expert. The source said the prescribing physician’s testimony thereby barred plaintiff Erin Hexum’s claims.

T. Matthew Leckman of Pogust,...
To view the full article, register now.